On 13 August, the exemption that let India's small furniture makers and importers skip BIS certification runs out: the amendment trade press covered in February added narrow import and stock exceptions, but never touched this date

A relief measure and a deadline, in the same order, moving on different clocks

The Furniture (Quality Control) Order, 2025 does not set one blanket furniture standard. It maps six distinct product categories to six separate 2022 Indian Standards: Work Chairs (IS 17631:2022), General Purpose Chairs and Stools (IS 17632:2022), Tables and Desks (IS 17633:2022), Storage Units (IS 17634:2022), Beds (IS 17635:2022) and Bunk Beds (IS 17636:2022). Each category needs its own BIS licence and its own ISI mark before a product in it can be manufactured, imported or sold in India. Large and medium enterprises had to comply from 14 February 2026. Micro and small enterprises, classified under the Micro, Small and Medium Enterprises Development Act, 2006 and registered on the Udyam portal, were given an exemption running until the expiry of eighteen months from the order's 13 February 2025 notification date, which lands on 13 August 2026. The February 2026 amendment that most compliance trackers wrote about did something else entirely: it gave any manufacturer, regardless of size, a capped allowance to import unmarked units for research and development, let anyone holding pre-deadline stock keep selling it for a further twelve months, and let exporters bring in unmarked components for goods that leave India rather than being sold there. All three are narrow, conditional carve-outs layered onto the base rule. None of them moved the one date that decides whether a small furniture business can keep operating at all.

The numbers behind 13 August

One number is how many separate product categories, and separate licences, the order actually covers. One is the length of the exemption clock that just ran out. The third is the size of the one exception a manufacturer can still use today, and how tightly it is capped.

The real subject: an exemption expiring on schedule, not a rule getting easier

The February 2026 amendment gave the furniture QCO a relief narrative: capped R&D imports, a stock clearance window, an export carve-out, changes that read, correctly, as the government responding to industry pressure. That narrative sat on top of a separate, older clock that the amendment never touched. The eighteen-month exemption for micro and small enterprises was set the day the order was notified, 13 February 2025, and it was always going to expire on 13 August 2026 regardless of what else DPIIT added in between. A business that read the February amendment as evidence the rule was softening, and assumed its own compliance runway had moved with it, is now on the wrong side of a deadline it may not have been tracking as a deadline at all. The classification that mattered from day one, MSMED Act size, recorded on Udyam, not the amendment that made the trade headlines, is what decides whether a furniture manufacturer or importer can legally keep operating in India today.

Why it matters for brands

For any retail or consumer-goods brand that imports or sells furniture-category products into India, camping and outdoor chairs, folding tables, storage units, bed frames, sold directly or through a local distributor, three things follow from today. First, confirm now, not next quarter, whether every supplier behind those SKUs already holds a BIS licence, including any small-scale Indian manufacturer a brand sources components or finished pieces from: a supplier that was compliant yesterday under the exemption is not compliant today without one, and the obligation to hold a valid licence sits with whoever manufactures, imports or sells the product, not just the brand on the label. Second, treat classification as a per-category exercise: a product range spanning chairs, tables and storage furniture needs BIS licences mapped to each of the relevant Indian Standards, not one blanket approval, so an SKU-by-SKU mapping against IS 17631 through IS 17636 is the only way to know actual exposure. Third, do not read the February 2026 amendment as general relief: its three carve-outs, capped R&D imports, a twelve-month stock clearance window, export-component imports, are narrow and conditional, each with its own limit and paperwork, and none of them is a substitute for holding a licence on a product a brand intends to sell in India after today.

Two ways to read 13 August